A detailed history of Nicholas Investment Partners, LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 71,559 shares of VERA stock, worth $3.31 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
71,559
Previous 59,129 21.02%
Holding current value
$3.31 Million
Previous $2.14 Million 47.83%
% of portfolio
0.35%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$34.09 - $46.71 $423,738 - $580,605
12,430 Added 21.02%
71,559 $3.16 Million
Q2 2024

Aug 07, 2024

BUY
$33.72 - $48.82 $1.99 Million - $2.89 Million
59,129 New
59,129 $2.14 Million

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.25B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.